AMILI is Southeast Asia's first precision gut microbiome company, utilizing advanced gut microbiome sequencing and a multi-ethnic microbiome database to enhance understanding of gut health. The company addresses the critical need for personalized gut health solutions by providing microbiome screening, gut microbiome transplants, and product validation services for healthcare partners.
Funding
$14.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EVFounders
Product
Problem
Current methods for analyzing and understanding the gut microbiome often lack the specificity needed for personalized health interventions, particularly within diverse Asian populations. Existing solutions may not adequately account for the unique dietary habits, genetic backgrounds, and environmental factors that influence gut health in these populations. This limitation hinders the development of targeted therapies and nutritional strategies for optimizing individual well-being.
Solution
AMILI leverages advanced gut microbiome sequencing and a comprehensive, multi-ethnic Asian microbiome database to provide precision gut health solutions. The company offers microbiome screening services to identify imbalances and potential health risks, as well as gut microbiome transplant services. AMILI also partners with healthcare companies to validate the gut health effects of their products and co-develop gut-friendly formulations. By combining cutting-edge research with a focus on Asian populations, AMILI aims to deliver personalized insights and interventions that improve gut health outcomes.
Target Audience
AMILI's primary customers include healthcare providers, researchers, and food and supplement companies seeking to leverage the gut microbiome for personalized health solutions, with a particular focus on the Asian population.
Features
- Advanced gut microbiome sequencing for detailed analysis of microbial composition and function
- Multi-ethnic Asian gut microbiome database for population-specific insights
- Gut microbiome screening services to identify individual imbalances and health risks
- Gut microbiome transplant services for targeted therapeutic interventions
- Product validation services to assess the impact of food and supplements on gut health
- Co-development of gut-friendly products with healthcare partners
- ISO 27001:2013 (information security) and ISO 9001:2015 (quality management) certifications